155 related articles for article (PubMed ID: 2950629)
21. Effect of cyclosporin A on human lymphocyte responses in vitro. V. Analysis of responding T lymphocyte subpopulations in primary MLR with monoclonal antibodies.
Hess AD; Donnenberg AD; Tutschka PJ; Santos GW
J Immunol; 1983 Feb; 130(2):717-21. PubMed ID: 6217251
[No Abstract] [Full Text] [Related]
22. Mechanism of action of cyclosporine: role of calmodulin, cyclophilin, and other cyclosporine-binding proteins.
Hess AD; Colombani PM
Transplant Proc; 1986 Dec; 18(6 Suppl 5):219-37. PubMed ID: 2947365
[No Abstract] [Full Text] [Related]
23. Prostaglandin E1 and E2 suppression of in vitro lymphoid responses to alloantigen.
Bowes LG; Dumble LJ; Pollak R; Ruwart MJ; Francis DM; Hunter S; Clunie GJ
Transplant Proc; 1989 Oct; 21(5):3769-70. PubMed ID: 2530676
[No Abstract] [Full Text] [Related]
24. Effect of cyclosporin A on human lymphocyte responses in vitro. III. CsA inhibits the production of T lymphocyte growth factors in secondary mixed lymphocyte responses but does not inhibit the response of primed lymphocytes to TCGF.
Hess AD; Tutschka PJ; Santos GW
J Immunol; 1982 Jan; 128(1):355-9. PubMed ID: 6459374
[TBL] [Abstract][Full Text] [Related]
25. Tumor promoters in conjunction with calcium ionophores mimic antigenic stimulation by reactivation of alloantigen-primed murine T lymphocytes.
Isakov N; Altman A
J Immunol; 1985 Dec; 135(6):3674-80. PubMed ID: 2999231
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin A.
Morris PJ
Transplantation; 1981 Nov; 32(5):349-54. PubMed ID: 6460358
[No Abstract] [Full Text] [Related]
27. Sensitivity of activated human lymphocytes to cyclosporine and its metabolites.
Zeevi A; Venkataramanan R; Burckart G; Wang CP; Murase N; Van Thiel DH; Starzl TE; Makowka L; Duquesnoy RJ
Hum Immunol; 1988 Feb; 21(2):143-53. PubMed ID: 2966788
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of immunosuppression by FK506. Preservation of T cell transmembrane signal transduction.
Bierer BE; Schreiber SL; Burakoff SJ
Transplantation; 1990 Jun; 49(6):1168-70. PubMed ID: 1694317
[No Abstract] [Full Text] [Related]
29. Immunosuppressive mechanism of action of deoxymethylspergualin--a human in vitro assay.
Takano Y; Takahara S; Jiang H; Kokado Y; Kameoka H; Moutabarrik A; Ishibashi M; Okuyama A
Transplant Proc; 1992 Aug; 24(4):1372-4. PubMed ID: 1386697
[No Abstract] [Full Text] [Related]
30. Effect of FK-506 and cyclosporine on human lymphocyte responses in vitro.
Beck Y; Akiyama N
Transplant Proc; 1989 Jun; 21(3):3464-7. PubMed ID: 2472695
[No Abstract] [Full Text] [Related]
31. In vitro and in vivo comparative studies on immunosuppressive properties of cyclosporines A, C, D and metabolites M1, M17 and M21.
Sadeg N; Pham-Huy C; Rucay P; Righenzi S; Halle-Pannenko O; Claude JR; Bismuth H; Duc HT
Immunopharmacol Immunotoxicol; 1993; 15(2-3):163-77. PubMed ID: 8349948
[TBL] [Abstract][Full Text] [Related]
32. Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.
Zeevi A; Duquesnoy R; Eiras G; Rabinowich H; Todo S; Makowka L; Starzl TE
Transplant Proc; 1987 Oct; 19(5 Suppl 6):40-4. PubMed ID: 2445073
[No Abstract] [Full Text] [Related]
33. Cyclosporine metabolites suppress T cell proliferation induced by concanavalin A.
Dindzans VJ; Wong PY; Mee AV; Cheung F; Abecassis M; Cole EH; Cohen Z; Levy GA
Transplant Proc; 1987 Aug; 19(4):3490-3. PubMed ID: 3303521
[No Abstract] [Full Text] [Related]
34. [Mechanism of action of cyclosporin A].
Wagner H; Hardt C; Heeg K
Internist (Berl); 1985 Sep; 26(9):530-3. PubMed ID: 2933358
[No Abstract] [Full Text] [Related]
35. Heterogeneity of dialysis patient lymphocyte responses to cyclosporine.
Briggs WA; Gao ZH; Xing JJ; Scheel PJ; Gimenez LF; Burdick JF
Transplant Proc; 1996 Aug; 28(4):2063-5. PubMed ID: 8769157
[No Abstract] [Full Text] [Related]
36. A comparison of the effects of cyclosporine and steroids on human T lymphocyte responses.
Freed BM; Stevens C; Zhang G; Rosano TG; Lempert N
Transplant Proc; 1988 Apr; 20(2 Suppl 2):233-9. PubMed ID: 3284070
[No Abstract] [Full Text] [Related]
37. Lymphocyte activation by OKT3: cyclosporine sensitivity and synergism with phorbol ester.
Kay JE; Benzie CR
Immunology; 1986 Feb; 57(2):195-9. PubMed ID: 3485075
[TBL] [Abstract][Full Text] [Related]
38. The relationship of immunological responsiveness to suppression of cellular responses by cyclosporine in vitro.
MacSween JM; Cohen AD; Eastwood SL; Fernandez LA
Transplant Proc; 1987 Feb; 19(1 Pt 2):1202-4. PubMed ID: 2978876
[No Abstract] [Full Text] [Related]
39. Cyclosporin A and G inhibition of cytokine production.
Szturm K; Jeffery JR; Rush DN; McKenna RM
Transplant Proc; 1989 Feb; 21(1 Pt 1):857. PubMed ID: 2705251
[No Abstract] [Full Text] [Related]
40. Prostaglandin E2 acts at two distinct pathways of T lymphocyte activation: inhibition of interleukin 2 production and down-regulation of transferrin receptor expression.
Chouaib S; Welte K; Mertelsmann R; Dupont B
J Immunol; 1985 Aug; 135(2):1172-9. PubMed ID: 2989362
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
